Most Recent Posts
A Reuters article I read recently raises important issues about the cost of cancer care. But it missed an important theme: New treatments are changing and improving the way we treat cancer and while it's important to keep an eye on healthcare costs, we must see the bigger picture, which is the potential of new medicines.
We sat down with Michael Sapienza, the Executive Director and Founder of Chris4Life, a patient advocacy organization committed to improving the treatment experience for patients and caregivers, and to dramatically raising awareness about colon cancer.
Q: How did Chris4Life get started?
Today we have a guest post from Dr. Salvatore Giorgianni, who is an expert in men's health and a pharmacist. He is an advisor and board member for Men's Health Network and serves as Chair-elect of the American Public Health Association Men's Health Caucus.
Continuing on the theme of progress - and the ongoing work of researchers - in battling cancer, today I'd like to point out "Fighting Cancer: Don't Let Our Progress Slow," a column by our president and CEO John J. Castellani that the Huffington Post published yesterday.
I appreciated Bruce Booth's thoughtful discussion of the investment side of cancer research in Forbes last week.
Today, the Boston Healthcare Associates released "Recognizing Value in Oncology Innovation," a noteworthy paper about the imp
Andrea Clay is the National Partnership & Strategy Director for the Colon Cancer Alliance. She is the mom of two teenage girls and two chocolate labs. Both her husband and father-in-law were diagnosed with colon cancer the same week in 2004. Here is her view on the fight against cancer.
I can still vividly remember the year Congress declared war on cancer. It was 1971 and I was a few months away from graduation at my college in upstate New York. There wasn't a lot of optimism in the country then - we were in the middle of the Vietnam War and protests were taking place on college campuses across the country, including my own.
Today we have a Q&A with Ryan M. Hohman, JD, MPA, Director, Communications & Policy at Friends of Cancer Research (Friends), a patient advocacy organization and think tank based in Washington, DC.
Recently PhRMA staff volunteered at the Special Olympics of DC (SODC) Summer Games. And as excited as the SODC was regarding our participation, my colleagues were even more thrilled to be there. This was PhRMA's first time being involved with the games and it was such an amazing experience. You can hear from a few of my colleagues below.
Marv Shepherd, PhD, president of the Partnership for Safe Medicines, comments on World Anti Counterfeiting Day.
We believe it is only fitting that on the last day of the American Society of Clinical Oncologist's (ASCO) annual meeting that the researchers and developers of life-enhancing medicines - biopharmaceutical research companies - highlight the progress that has been made in the war against cancer.
In The Hill today, reporter Elise Viebeck reports from the recent American Society of Clinical Oncology meeting about the increasing number of new cancer medicines reaching the Food and Drug Administration